Shortened High-dose Palliative Radiotherapy for Lung Cancer
This study, called SHiP-Rt, is for people with advanced lung cancer. It's investigating if a new way of giving radiotherapy can be shorter and just as effective as the current standard treatment. Radiotherapy uses high-energy rays to shrink tumours and help with symptoms like pain or breathing difficulties. The new treatment involves giving a slightly higher dose of radiotherapy over 6 sessions, rather than 12, potentially reducing the overall time spent in hospital. Researchers want to ensure this quicker approach is safe and helps patients feel better. This is not a study about curing cancer, but about improving quality of life and managing symptoms using modern radiotherapy techniques.
Em resumo
Sobre o que é este estudo?
When someone has advanced lung cancer, treatment often focuses on managing symptoms and improving comfort. One common treatment is radiotherapy, which uses high-energy rays to shrink tumours. This can help with things like pain, coughing, or breathlessness. The usual way to give this radiotherapy is over a period of about 16 days, with 12 separate treatment sessions.
This new study, called SHiP-Rt, is looking at whether we can make this radiotherapy course much shorter. Instead of 12 sessions over 16 days, they want to see if giving a slightly higher dose over just 6 sessions, spread out every other day, is just as safe and effective. The goal is to see if this quicker treatment helps patients feel better and manage their symptoms, while also potentially reducing the number of hospital visits.
The researchers will be using all the latest planning and delivery techniques for radiotherapy to make sure the treatment is as accurate and safe as possible. They want to find out if this new, more convenient schedule can offer similar benefits to patients as the current standard treatment. It's important to remember that this study is about easing symptoms and improving quality of life, not about finding a cure.
Pontos principais
- This study compares standard radiotherapy with a new, shorter treatment for advanced lung cancer.
- The aim is to help manage symptoms and improve your quality of life.
- It uses modern radiotherapy techniques for accuracy and safety.
- You would either have 12 or 6 radiotherapy sessions.
- A participação é voluntária, e você pode se retirar a qualquer momento.
Quem pode ser elegível?
This study is for adults aged 18 and over who have a type of lung cancer called non-small cell lung cancer that has either spread locally or to other parts of the body (this is called stage IV cancer). You might be suitable if you haven't had any treatment for your cancer yet, or if you've had some initial treatment (like chemotherapy, immunotherapy, or targeted therapy) and your cancer hasn't worsened significantly.
For you to be considered, your doctor must believe you are healthy enough to receive the standard high-dose palliative radiotherapy. You'll also need to sign a consent form to show you understand and agree to take part. If you've had initial treatment, there needs to be a short break (about 3-4 weeks) before starting radiotherapy on this study. If you haven't had any treatment, you should be able to start your main cancer treatment within 3-4 weeks of joining the study.
There are also some reasons why you wouldn't be able to join. For example, if you have a medical reason that makes lung radiotherapy unsafe for you, or if you've already had radiotherapy to the same area being treated in this study. You also wouldn't be eligible if you have more than one active cancer, are taking certain medications for conditions like rheumatoid arthritis, or if your doctors think your life expectancy is less than 6 months. It's also important that you would be able to attend all study appointments.
Este estudo pode ser adequado para você?
Responda a estas perguntas rápidas para ver se você pode ser elegível. Este é apenas um guia — a decisão final é da equipe de pesquisa.
- Você tem 18 anos ou mais?
- Do you have stage IIIB, IIIC, or IV non-small cell lung cancer?
- Have you had no prior treatment for this cancer, or only one round of initial treatment (like chemo or immunotherapy) where your cancer hasn't worsened significantly?
- Are you able to start your main cancer treatment within 3-4 weeks if you haven't started already, or had a 3-4 week break since your last treatment?
- Have you NOT had radiotherapy to your chest previously for this lung cancer?
- Do your doctors think you can handle high-dose palliative radiotherapy?
O que envolve a participação?
If you decide to take part in this study, you'll either receive the standard radiotherapy treatment (12 sessions over about 16 days) or the new, shorter treatment (6 sessions every other day). Your study doctor will explain which treatment you would receive. Both treatments involve attending the hospital for your radiotherapy sessions.
Before you start, you'll have appointments for planning your radiotherapy, which might include scans. During your treatment, the hospital team will monitor you closely to see how you're responding and if you're experiencing any side effects. After your radiotherapy is finished, you'll have follow-up appointments to check on your health and how well the treatment has worked to manage your symptoms. The total duration of your participation will involve the treatment period itself, plus ongoing check-ups as determined by your care team, to monitor the long-term effects.
Riscos e benefícios potenciais
Localizações (4)
- Hospitais Universitários de North Midlands NHS TrustCódigo postal verificadoStoke-on-Trent, Reino Unido
- University Hospitals Coventry and WarwickshireCódigo postal verificadoCoventry, United Kingdom
- University Hospitals Birmingham NHS Foundation TrustCódigo postal verificadoBirmingham, Reino Unido
- The Shrewsbury and Telford Hospital NHS TrustCódigo postal verificadoShrewsbury, United Kingdom
Perguntas frequentes
What is radiotherapy?
Radiotherapy uses high-energy rays to shrink tumours and help with symptoms like pain or trouble breathing.
Qual é o principal objetivo deste estudo?
The main goal is to find out if a shorter, more intense course of palliative radiotherapy is as safe and effective as the standard treatment for managing lung cancer symptoms.
Will this study cure my cancer?
No, this study is focused on improving symptoms and quality of life for people with advanced lung cancer, not on finding a cure.
How many times would I need to go to the hospital for treatment?
You would either have 12 sessions over about 2.5 weeks (standard) or 6 sessions every other day (new shorter treatment).
Posso sair do estudo se mudar de ideia?
Sim, você pode deixar o estudo a qualquer momento sem que isso afete seu atendimento médico.
Como saber mais
Sempre consulte seu médico ou especialista antes de decidir participar de um estudo.
Discussão
Discussão da comunidade
Desenvolvido pelo nosso fórum em community.patient.info. Por favor, seja respeitoso — isto não é um conselho médico.